Use of HER2-targeting antibody-drug conjugate in treatment of HER2-low expressing breast cancer
The disclosure provides uses of a HER2-targeting antibody-drug conjugate in the preparation of a medicine for treating patients with HER2-low expressing breast cancer.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
01.04.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The disclosure provides uses of a HER2-targeting antibody-drug conjugate in the preparation of a medicine for treating patients with HER2-low expressing breast cancer. |
|---|---|
| AbstractList | The disclosure provides uses of a HER2-targeting antibody-drug conjugate in the preparation of a medicine for treating patients with HER2-low expressing breast cancer. |
| Author | FANG, JIAN-MIN SU, XIAO-HONG |
| Author_xml | – fullname: FANG, JIAN-MIN – fullname: SU, XIAO-HONG |
| BookMark | eNqNy0sKwjAURuEMdOBrD9cFBGy6ApFKx1JxWNL0b6jUm5Lcou5eBXHs6Ey-s1QzDoyFqs8JFDoqi5PRYqOH9OzJsvRNaJ-6jZMnF_g6eSugnkkirNzA8tuGcCc8xoiUPm_zBknIWXaIazXv7JCw-XaltseiOpQaY6iRRuvAkLq6mJ3Jszwz2T7_x7wAKFU9uQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | TW202313121A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_TW202313121A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:45:33 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_TW202313121A3 |
| Notes | Application Number: TW202211118596 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230401&DB=EPODOC&CC=TW&NR=202313121A |
| ParticipantIDs | epo_espacenet_TW202313121A |
| PublicationCentury | 2000 |
| PublicationDate | 20230401 |
| PublicationDateYYYYMMDD | 2023-04-01 |
| PublicationDate_xml | – month: 04 year: 2023 text: 20230401 day: 01 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | REMEGEN CO., LTD |
| RelatedCompanies_xml | – name: REMEGEN CO., LTD |
| Score | 3.517819 |
| Snippet | The disclosure provides uses of a HER2-targeting antibody-drug conjugate in the preparation of a medicine for treating patients with HER2-low expressing breast... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Use of HER2-targeting antibody-drug conjugate in treatment of HER2-low expressing breast cancer |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230401&DB=EPODOC&locale=&CC=TW&NR=202313121A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUaP4kZoY3hoZ68ZeFiPbCDHhI2QIb4RunULMRmAE9a_32g3wRd_6kbu0116vd_21BXiIWBQaOHNoVVhVyqK6TjnndcpMzRQMd3OB-rSv3TFbA_YyMkYFmG3uwqh3QtfqcUTUqAD1PVXr9XwXxHIVtnL5yKdYlDw1fdut5N6xjHCib-w2bK_XdbtOxXFsf1jp9FWdpms17XkP9muGbkr4n_fakLdS5r9NSvMEDnrILU5PofD9XoIjZ_PzWgkO2_mBNyZz3VuewXiwFCSJSMvr12gG4EazQ1AyU56EXzRcrN4IerezlYyMkWlMtiDyLdlHsibiM8O-Ii2XiPSUBHLkF-dw3_R8p0WxpeOtWMb-cNcp_QKKcRKLSyCBZU5Mi09wn8RYNahzFLiY6JqIAjTHUXgF5b_5lP-rvIZjmclwKzdQTBcrcYsmOeV3SpY_jbWQmA |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4VRPD2-LGyuCFGNlGpvIVMoS3hW6dQsxGYAvqX--1fPmib00vvbTXXq93_bUHcBfSMCjjylFUXlUVGlZ0hTFWUaihGZziac6XSftabcPp0-dheZiByfotjPwndCE_R0SN8lHfE7lfT7dBLEtiK-f3bIxV8UPDrVnFlXcsIpzoG1v1mt3tWB2zaJo1d1Bs9yRN07WS9rgDu6hTqoD_2a918Spl-tukNA5hr4vcouQIMt_veciZ68xredhvrS68sbjSvfkxeP05J3FIHLtXUpYAbjQ7BCUzZnHwpQSz9I2gdztJRWSMjCOyAZFvmn3EC8I_l9hXbMsEIj0hvpj52QncNmzXdBTsqbcRi-cOtoPSTyEbxRE_A-JXjZFRZSM8J1Gq-hWGAucjXeOhj-Y4DM6h8Defwn_EG8g5bqvpNZ_aLxdwIAhLDMslZJNZyq_QPCfsWsr1B3ZFk4I |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+HER2-targeting+antibody-drug+conjugate+in+treatment+of+HER2-low+expressing+breast+cancer&rft.inventor=FANG%2C+JIAN-MIN&rft.inventor=SU%2C+XIAO-HONG&rft.date=2023-04-01&rft.externalDBID=A&rft.externalDocID=TW202313121A |